Menu
GeneBe

RAD51B

RAD51 paralog B

Basic information

Region (hg38): 14:67819778-68730218

Previous symbols: [ "RAD51L1" ]

Links

ENSG00000182185NCBI:5890OMIM:602948HGNC:9822Uniprot:O15315AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RAD51B gene.

  • not provided (59 variants)
  • Hereditary breast ovarian cancer syndrome (38 variants)
  • Hereditary cancer-predisposing syndrome (11 variants)
  • Inborn genetic diseases (9 variants)
  • not specified (1 variants)
  • Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype (1 variants)
  • Poly (ADP-Ribose) polymerase inhibitor response (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RAD51B gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
2
clinvar
5
missense
20
clinvar
3
clinvar
5
clinvar
28
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
3
splice region
1
1
2
non coding
1
clinvar
10
clinvar
42
clinvar
53
Total 0 0 22 17 51

Variants in RAD51B

This is a list of pathogenic ClinVar variants found in the RAD51B region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-67823550-A-G Hereditary cancer-predisposing syndrome Uncertain significance (Aug 01, 2018)584555
14-67823568-G-A Hereditary cancer-predisposing syndrome • Hereditary breast ovarian cancer syndrome Conflicting classifications of pathogenicity (Apr 19, 2022)584553
14-67823627-G-A Hereditary breast ovarian cancer syndrome • Hereditary cancer-predisposing syndrome Likely pathogenic (Jan 01, 2020)221910
14-67823652-T-C Benign (Jul 20, 2018)1292857
14-67823655-T-G Hereditary breast ovarian cancer syndrome Benign (Apr 19, 2022)1264893
14-67823709-T-C Benign (Jun 23, 2018)1270487
14-67823747-G-A Benign (Jun 23, 2018)1271766
14-67823803-T-G Benign (Jun 19, 2021)1259949
14-67825181-C-T Benign (Jun 19, 2021)1238204
14-67825190-G-A Benign (Jun 19, 2021)1270763
14-67825246-T-A Benign (Jun 21, 2021)1241170
14-67825402-T-C Hereditary cancer-predisposing syndrome Likely benign (Dec 01, 2015)223992
14-67825470-T-C Hereditary breast ovarian cancer syndrome Benign (Apr 19, 2022)714335
14-67825494-A-G not specified Uncertain significance (Feb 05, 2024)3151062
14-67825513-G-A not specified Uncertain significance (Jan 19, 2024)3151063
14-67825518-C-T Hereditary cancer-predisposing syndrome Uncertain significance (Nov 20, 2015)224591
14-67835047-G-T Hereditary breast ovarian cancer syndrome Benign (Apr 19, 2022)1248492
14-67835050-G-GA Benign (Sep 25, 2018)1270868
14-67835059-C-T Hereditary breast ovarian cancer syndrome Benign (Apr 19, 2022)1231988
14-67835084-A-G Hereditary breast ovarian cancer syndrome Uncertain significance (May 01, 2019)830255
14-67835107-G-A Hereditary cancer-predisposing syndrome Uncertain significance (Aug 01, 2018)584552
14-67835176-G-A not specified Uncertain significance (Dec 14, 2023)3151064
14-67835204-A-G Hereditary breast ovarian cancer syndrome Benign (Apr 19, 2022)726378
14-67835410-A-G Benign (Jun 19, 2021)1296249
14-67864720-G-A Benign (Jun 19, 2021)1183458

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RAD51Bprotein_codingprotein_codingENST00000487270 10910440
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.08e-150.0041912564601021257480.000406
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6721691950.8650.000009442459
Missense in Polyphen2946.7520.62029582
Synonymous0.3396871.60.9490.00000333778
Loss of Function-0.5632118.41.149.39e-7233

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007690.000769
Ashkenazi Jewish0.000.00
East Asian0.0009360.000925
Finnish0.000.00
European (Non-Finnish)0.0002940.000290
Middle Eastern0.0009360.000925
South Asian0.0009160.000915
Other0.0005020.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. May promote the assembly of presynaptic RAD51 nucleoprotein filaments. Binds single-stranded DNA and double-stranded DNA and has DNA-dependent ATPase activity. Part of the RAD21 paralog protein complex BCDX2 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 acts downstream of BRCA2 recruitment and upstream of RAD51 recruitment. BCDX2 binds predominantly to the intersection of the four duplex arms of the Holliday junction and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. {ECO:0000269|PubMed:11751635, ECO:0000269|PubMed:11751636, ECO:0000269|PubMed:11842113, ECO:0000269|PubMed:12441335, ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}.;
Disease
DISEASE: Note=A chromosomal aberration involving RAD51B is found in pulmonary chondroid hamartoma. Translocation t(6;14)(p21;q23- 24) with HMGA1. {ECO:0000269|PubMed:11978964}.; DISEASE: Note=A chromosomal aberration involving RAD51B is found in uterine leiomyoma. Translocation t(12;14)(q15;q23-24) with HMGA2. {ECO:0000269|PubMed:12649198, ECO:0000269|PubMed:9892177}.;
Pathway
Homologous recombination - Homo sapiens (human);HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA);DNA Repair;DNA Double-Strand Break Repair;Homology Directed Repair;Factors involved in megakaryocyte development and platelet production;Hemostasis;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Resolution of D-loop Structures through Holliday Junction Intermediates;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Resolution of D-Loop Structures;HDR through Homologous Recombination (HRR) (Consensus)

Recessive Scores

pRec
0.102

Intolerance Scores

loftool
rvis_EVS
0.93
rvis_percentile_EVS
89.79

Haploinsufficiency Scores

pHI
0.178
hipred
N
hipred_score
0.187
ghis

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rad51b
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
double-strand break repair via homologous recombination;DNA repair;DNA recombination;reciprocal meiotic recombination;blood coagulation;positive regulation of G2/M transition of mitotic cell cycle
Cellular component
nucleus;nucleoplasm;replication fork;Rad51B-Rad51C-Rad51D-XRCC2 complex
Molecular function
four-way junction DNA binding;DNA binding;double-stranded DNA binding;single-stranded DNA binding;protein binding;ATP binding;DNA-dependent ATPase activity